Biotech Values

[DewDiligence]

…the point is not that the figure you cite is flexible but that a decreasing amount of the AG, or altogether elimination of the AG, is going to translate in a higher figure of mL sales by definition, which makes it more likely that the threshold is exceeded and MNTA shifts into the profit share.

This is indeed true, but it’s not what I meant by a variable threshold.